Skip to main content

Israeli innovations in medical tech embraced worldwide

In Europe, the US, Africa, and now also in Gulf states, hospitals and healthcare systems are adopting Israeli med-tech companies' new products.

Israel biomed
A technician displays a sample of an anti-viral nose spray developed by biotech company SaNOtize at the company's lab in Nezz Ziona on April 7, 2021. — EMMANUEL DUNAND/AFP via Getty Images

Israel’s 20th Biomed Conference will take place on May 10. Its organizers expect an even larger participation than in previous years. For the local med-tech and health-tech industries, the conference offers an excellent opportunity to showcase Israeli innovation.

Viz.ai, for example, announced on April 7 that it had raised over $100 million more, giving it an estimated value of $1.2 billion. This round of funding was led by two American venture capital funds, Tiger Global and Insight Partners. 

Israel Medtech was founded in 2020 to promote Israeli high-tech companies specializing in medical technologies. As such, it integrated well into the specific needs resulting from the coronavirus pandemic.

Yaron Yitzhari, CEO of Medtronics and general manager of the new umbrella organization, said in an interview just a few months later that the virus served as a kind of basic training that expedited the growth of the organization and the entire field.

SUBSCRIBER EXCLUSIVE

Continue reading this exclusive analysis

Original reporting and analysis unavailable elsewhere. Subscribe to AL-MONITOR to read this story and access everything we publish